| Category | Shares reserved | 20-08 | |
|---|---|---|---|
| Shares bid | Times | ||
| ∟QIB (Ex Anchor) | 11,71,200 | 42,82,800 | 3.66× |
| NII * | 9,60,000 | 47,59,200 | 4.96× |
| ∟bNII (> ₹10L) | 6,39,600 | 32,16,000 | 5.03× |
| ∟sNII (< ₹10L) | 3,20,400 | 15,43,200 | 4.82× |
| Total | 41,54,400 | 1,60,95,600 | 3.87× |
| Offer Type | Bookbuilding IPO |
| Sale Type | Fresh capital cum OFS |
| Listing At | NSE SME |
| Face Value | ₹ 10 per share |
| Price Band | ₹110 to ₹118 |
| Lot Size | 1200 shares |
| Total Issue Size | 58,51,200 shares (agg. up to ₹ 69 Cr) |
| Offer for Sale | 5,00,400 shares of ₹ 10 (agg. up to ₹ 6 Cr) |
| ISIN | INE2JG601017 |
| Category | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 85.71% | 62.64% |
| Public | 14.29% | 37.36% |
| Total | 100% | 100% |
| EPS(₹) (pre → post) | 10.41 → 7.88 |
| P/E (x) (pre → post) | 11.34 → 14.97 |
| Market Cap at Offer Price | ₹268.18 Cr |
| Metric | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 93.62 | 56.45 | 48.78 |
| Total Income | 63.38 | 38.55 | 35.79 |
| Profit After Tax | 17.38 | 11.14 | 7.14 |
| EBITDA | 30.90 | 20.97 | 15.53 |
| NET Worth | 53.15 | 35.77 | 24.75 |
| Reserves and Surplus | 36.46 | 34.49 | 23.46 |
| Total Borrowing | 17.85 | 10.81 | 11.96 |
| ROE | 39.08% |
| ROCE | 34.66% |
| Debt/Equity | 0.34 |
| RoNW | 32.69% |
| PAT Margin | 27.90% |
| EBITDA Margin | 49.61% |
| NAV | 31.84 |
| Price to Book Value | 3.71 |
| Company | Issue price | P/E | Listing-day close |
|---|---|---|---|
| Modern Diagnostic & Research Centre | ₹90 | 11.04 | ₹94.99 |
| Invicta Diagnostic Ltd. | ₹85 | 14.51 | ₹96.70 |
| Gaudium IVF & Women Health Ltd. | ₹79 | 25.36 | ₹80.26 |
| Nephrocare Health Services Ltd. | ₹460 | 63.52 | ₹471.25 |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (IND) (Min) | 2 | 2,400 | ₹2,83,200 |
| Individual investors (IND) (Max) | 2 | 2,400 | ₹2,83,200 |
| S-HNI (Min) | 3 | 3,600 | ₹4,24,800 |
| S-HNI (Max) | 7 | 8,400 | ₹9,91,200 |
| B-HNI (Min) | 8 | 9,600 | ₹11,32,800 |
| Category | Shares | % of issue | Max allottees |
|---|---|---|---|
| QIB | 25,32,000 | 45.91% | 43.27% |
| − Anchor Investor | 13,60,800 | 23.26% | |
| − QIB (Ex. Anchor) | 11,71,200 | 20.02% | |
| NII (HNI) | 9,60,000 | 17.41% | 16.41% |
| − bNII > ₹10L | 6,39,600 | 10.93% | |
| − sNII < ₹10L | 3,20,400 | 5.48% | |
| Retail | 20,23,200 | 36.68% | 34.58% |
| Market Maker | 3,36,000 | 5.74% | |
| Total | 58,51,200 | 100.00% | 100.00% |
| Date | GMP ₹ | Implied |
|---|---|---|
| 2026-08-20 | 0 | +0.0% |
| 2026-08-20 | 0 | +0.0% |
| 2026-08-19 | 0 | +0.0% |
| 2026-08-19 | 0 | +0.0% |
| 2026-08-19 | 0 | +0.0% |
| 2026-08-19 | 0 | +0.0% |
| 2026-08-19 | 0 | +0.0% |
| 2026-08-19 | 0 | +0.0% |
| 2026-08-19 | 0 | +0.0% |
| 2026-08-19 | 0 | +0.0% |
| 2026-08-18 | 0 | +0.0% |
| 2026-08-18 | 0 | +0.0% |
| 2026-08-18 | 0 | +0.0% |
| 2026-08-18 | 0 | +0.0% |
Pramodini Medicare IPO is a book build issue of ₹69.04 crores. The issue is a combination of fresh issue of 0.54 crore shares aggregating to ₹63.14 crores and offer for sale of 0.05 crore shares aggregating to ₹5.90 crores.
Pramodini Medicare IPO bidding started from Aug 12, 2026 and ended on Aug 14, 2026. The allotment for Pramodini Medicare IPO was finalized on Aug 17, 2026. The shares got listed on the NSE SME on Aug 19, 2026.
Pramodini Medicare IPO is set final issue price at ₹118 per share. The lot size for an application is 1,200 shares. The minimum amount of investment required by an individual investor (retail) is ₹2,83,200 (2,400 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (3,600 shares), amounting to ₹4,24,800.
Smart Horizon Capital Advisors Pvt.Ltd. is the book running lead manager and Purva Sharegistry (India) Pvt.Ltd. is the registrar of the issue. The Market Maker of the company are Rainbow Securities Pvt.Ltd. , Shreni Shares Ltd.
| Object | ₹ Cr |
|---|---|
| Funding of capital expenditure for purchase of Medical Equipments towards Existing and Pro | 45.15 |
| General corporate purposes and unidentified inorganic acquisition | 10.76 |
| Issue Expenses | 7.90 |
| Name | Category | Shares offered |
|---|---|---|
| Chalasani Kuldeep Kumar | Promoter | 2,14,400 |
| Chalasani Kavitha | Promoter | 1,43,000 |
| Sri Ram Medicare Pvt.Ltd. | Promoter | 1,43,000 |
| Total | 5,00,400 |